Danish dermatology specialist LEO Pharma today announced that Swissmedic, Switzerland’s national regulatory agency for ...

Meanwhile, Switzerland’s relative regulatory independence, via its own health authority Swissmedic, could provide some ...

Anzupgo is the first topical pan-Janus kinase (JAK) inhibitor to be approved in Switzerland specifically for moderate to ...

AdvaMed has reported that its member companies have provided $26.8 million in medical supplies, along with $4.1 million in cash donations.

New psychoactive substances are synthetic substances with narcotic-like effects. They are sold as intoxicants and also called designer drugs. Their consumption is a health risk: it is not known how ...

Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro ...

Canaccord Genuity analyst Edward Nash has maintained their bullish stance on TVTX stock, giving a Buy rating yesterday. Edward Nash has given ...

Citi analyst Mathieu Chevrier maintained a Buy rating on CSL (CMXHF – Research Report) today and set a price target of A$345.00. The ...

SAN DIEGO - Travere Therapeutics, Inc. (NASDAQ:TVTX) and CSL (OTC:CSLLY) Vifor announced that Swissmedic, the Swiss regulatory authority, has granted temporary marketing authorization for FILSPARI for ...

"Swissmedic approval further demonstrates our promise to deliver transformational medicines for patients with serious diseases in our areas of focus," said Emmanuelle Lecomte Brisset, Senior Vice ...

ST. GALLEN, Switzerland and SAN DIEGO, Oct. 17, 2024 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Swissmedic has granted temporary marketing ...